Роль загальноклінічних показників крові для прогнозування перебігу коронавірусної інфекції у хворих на COVID-19: систематичний огляд-Reference-Cited by-同舟云学术

Роль загальноклінічних показників крові для прогнозування перебігу коронавірусної інфекції у хворих на COVID-19: систематичний огляд

Published:2023-12-30 Issue:2 Volume:6 Page:
ISSN:2786-5258
Container-title:Notes in Current Biology
language:
Short-container-title:NCBio

Author:

Yushchuk A. Anna^ORCID,Korzhyk O. Olha^ORCID,Pykaliuk V. Vasyl^ORCID

Abstract

Abstract. The course of coronavirus infection in patients with COVID-19 can cause systemic inflammation of the organism, and dysregulation of the immune system and the hemostasis system. Given the possibility of severe and recurrent cases of SARS-CoV-2 infection, it is imperative for clinicians to find reliable, cost-effective, and at the same time accessible blood-specific parameters that can serve as stratification markers for patients with confirmed COVID-19. The purpose of our review article is to highlight the modern research results on the characteristics of general clinical hematological parameters (complete blood count) in patients with COVID-19 and their use for predicting the course of the coronavirus infection. We used bibliosemantic, analytical, and logical methods when writing a systematic review, as well as a generalization method. We searched and selected scientific publications by keywords in bibliographic databases, analyzed and summarized the results. The indicators of the general blood analysis (an absolute count of neutrophils, lymphocytes, platelets, and monocytes) allow calculating several newly introduced indices of inflammation, such as NLR, dNLR, PLR, MLR, NLPR, AISI, SIRI, SII. The use of such indices at the stage of hospitalization in patients with confirmed COVID-19 can be used to predict the course of the disease and the probability of a critical condition or lethal outcome.

Publisher

Lesya Ukrainka Volyn National University

Reference22 articles.

1. Peng, J., Qi, D., Yuan, G., Deng, X., Mei, Y., Feng, L., Wang, D. Diagnostic value of peripheral hematologic markers for coronavirus disease 2019 (COVID-19): a multicenter, cross-sectional study. J Clin Lab Anal. 2020, 34, pp e23475

2. Fois, A.G., Paliogiannis, P., Scano, V., Cau, S., Babudieri, S., Perra, R., Ruzzittu, G., Zinellu, E., Pirina, P., Carru, C., Arru, L.B., Fancellu, A., Mondoni, M., Mangoni, A.A., Zinellu, A. The systemic inflammation index on admission predicts in-hospital mortality in COVID-19 patients. Molecules. 2020, 25, pp 5725.7.

3. Guan, W., Ni, Z., Hu, Y., Liang, W., Ou, C., He, J., Liu, L., Shan, H., Lei, C., Hui, DSC., Du, B., Li, L., Zeng, G., Yuen, K-Y., Chen, R., Tang, C., Wang, T., Chen, P., Xiang, J., Li, S-y., Wang, J-l., Liang, Z-j., Peng, Y-x., Wei, L., Liu, Y., Hu, Y-h., Peng, P., Wang, J-m., Chen, Z., Li, G., Zheng, Z-j., Qiu, S-q., Luo, J., Ye, C-j., Zhu, S-y., Zhong, N-s. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020, 382, pp 1708-1720

4. Yushchuk, A., Pykaliuk, V., Korzhyk, O. Hematocytological, biochemical, and hemostasis parameters' role in predicting the possibility of the various forms of the COVID-19 course in hospitalized Ukrainian patients: A cross-sectional study. Health Sci Rep. 2023, 6 (7), pp e1403.

5. Az, A., Sogut, O., Akdemir, T., Ergenc, H., Dogan, Y., Cakirca, M. Impacts of demographic and clinical characteristics on disease severity and mortality in patients with confirmed COVID-19. Int J Gen Med Volume. 2021, 14, pp 2989-3000